☆ 4.6 Letter

Potential serum biomarkers of treatment response to ustekinumab in patients with psoriasis: a pilot study

BRITISH JOURNAL OF DERMATOLOGY (2015)

Journal

BRITISH JOURNAL OF DERMATOLOGY

Volume 173, Issue 6, Pages 1536-1539

Publisher

WILEY-BLACKWELL

DOI: 10.1111/bjd.13997

Keywords

-

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Genome-Wide Association Study of Ustekinumab Response in Psoriasis

William T. Connell, Julie Hong, Wilson Liao

Summary: Genetic factors, including rs35569429 and HLA-C*06:02, are associated with the response to ustekinumab therapy in psoriasis. The presence of the deletion allele of rs35569429 and being HLA-C*06:02 negative are associated with a lower treatment response rate.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study

Filip Rob, Dagmar Schierova, Zuzana Stehlikova, Jakub Kreisinger, Radka Roubalova, Stepan Coufal, Martin Mihula, Zuzana Jackova, Miloslav Kverka, Tomas Thon, Klara Kostovcikova, Lukas Bajer, Pavel Drastich, Jana Tresnak Hercogova, Michaela Novakova, Martin Kolar, Martin Vasatko, Milan Lukas, Helena Tlaskalova-Hogenova, Zuzana Jiraskova Zakostelska

Summary: In this preliminary study, the longitudinal effect of ustekinumab on the immune system, skin and gut microbiota composition, and specific immune response to commensals was examined in patients with IBD. The findings provide valuable information for further understanding of the therapeutic effect and mechanism of ustekinumab.

PLOS ONE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Significantly Altered Serum Levels of NAD, AGE, RAGE, CRP, and Elastin as Potential Biomarkers of Psoriasis and Aging-A Case-Control Study

Adam Karas, Drahomira Holmannova, Pavel Borsky, Zdenek Fiala, Ctirad Andrys, Kvetoslava Hamakova, Tereza Svadlakova, Vladimir Palicka, Jan Krejsek, Vit Rehacek, Monika Esterkova, Helena Kovarikova, Lenka Borska

Summary: The study investigates potential markers of psoriasis and aging, finding increased levels of CRP, AGEs, and RAGE, and reduced levels of NAD among psoriatic patients compared to controls. There is a negative correlation between AGEs and NAD. The study suggests that psoriasis and other immune-mediated diseases contribute to accelerated aging through sustained systemic damage.

BIOMEDICINES (2022)

Add to Collection

Article Multidisciplinary Sciences

Evaluation of several serum interleukins as markers for treatment effectiveness in naive HIV infected patients: A pilot study

Cristian Jianu, Corina Itu-Muresan, Cristina Drugan, Irina Filipescu, Adriana Violeta Topan, Mihaela Elena Jianu, Ioana Iulia Morar, Sorana D. Bolboaca

Summary: This observational pilot study investigated the impact of different antiretroviral drugs on immune activation markers in HIV-infected patients. The results showed that all investigated drugs were effective in restoring immune markers, with Dolutegravir showing a tendency towards significant changes in IL-4 and IL-10. Further clinical trials with random allocation of medication and extensive follow-up are needed to replicate and validate these findings.

PLOS ONE (2021)

Add to Collection

Review Peripheral Vascular Disease

Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response

Kaitlin G. Scheer, Lisa M. Ebert, Michael S. Samuel, Claudine S. Bonder, Guillermo A. Gomez

Summary: Glioblastoma invasion, driven by interactions between tumor cells and blood vessels, leads to poor prognosis. Dysregulated microvasculature and vessels co-opted from surrounding brain tissue promote rapid tumor growth and invasion. Antiangiogenic agents targeting glioblastoma vasculature have limited efficacy, and the reasons for heterogeneous responses are unknown.

HYPERTENSION (2023)

Add to Collection

Article Rheumatology

Suppression of Serum Interferon-gamma Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus

Matteo Cesaroni, Loqmane Seridi, Matthew J. Loza, Jessica Schreiter, Kristen Sweet, Carol Franks, Keying Ma, Ashley Orillion, Kim Campbell, Robert M. Gordon, Patrick Branigan, Peter Lipsky, Ronald van Vollenhoven, Bevra H. Hahn, George C. Tsokos, Marc Chevrier, Shawn Rose, Frederic Baribaud, Jarrat Jordan

Summary: This study investigated the use of ustekinumab in treating patients with SLE and examined biomarker data, revealing a significant association between antibody conversion rates and sustained reductions in IFN gamma protein levels. Changes in serum levels of IL-17A, IL-17F, and IL-22 were not consistently linked to clinical response to ustekinumab.

ARTHRITIS & RHEUMATOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Baseline Serum Biomarkers Predict Response to a Weight Loss Intervention in Older Adults with Obesity: A Pilot Study

David H. H. Lynch, Blake R. R. Rushing, Wimal Pathmasiri, Susan McRitchie, Dakota J. J. Batchek, Curtis L. L. Petersen, Danae C. C. Gross, Susan C. J. Sumner, John A. A. Batsis

Summary: Caloric restriction and exercise are safe and effective interventions for weight loss in obese older adults, but responses vary. This study used metabolomics to identify metabolic profiles associated with weight loss. The results suggest that older adults with significant enrichment for caffeine metabolism are more likely to achieve ≥5% weight loss. Further research is needed to confirm these associations in larger studies.

METABOLITES (2023)

Add to Collection

Article Dermatology

Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris

Merav Koschitzky, Kristina Navrazhina, Michael S. Garshick, Juana Gonzalez, Joseph Han, Sandra Garcet, James G. Krueger

Summary: This study aimed to identify biomarkers of cardiovascular (CV) risk in psoriasis blood that are reduced by ustekinumab. The results showed that 43 out of 276 proteins were down-regulated after treatment, and 8 of them were initially elevated above thresholds associated with enhanced CV risk.

EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study

Indu Sinha, Rachel L. Fogle, Gizem Gulfidan, Anne E. Stanley, Vonn Walter, Christopher S. Hollenbeak, Kazim Y. Arga, Raghu Sinha

Summary: Breast cancer is a leading cause of death in women in the US, and current diagnostic methods have high false positivity rates. This study aimed to identify protein markers in saliva and serum for early breast cancer detection. Through rigorous analysis using iTRAQ technique, a total of 591 and 371 differentially expressed proteins were identified in saliva and serum samples, respectively. These proteins were mainly related to exocytosis, secretion, immune response, and signaling pathways. A network biology approach was used to evaluate potential biomarkers for breast cancer diagnosis and prognosis. The findings suggest that saliva and serum samples from the same women can provide a feasible platform for studying responsive proteomic profiles in benign and malignant breast disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Letter Dermatology

Serum tryptase levels in patients with psoriasis: a pilot study for a possible useful biomarker

G. Paolino, M. R. Di Nicola, M. Currado, P. Brianti, S. R. Mercuri

Summary: The study revealed varying levels of serum tryptase (ST) in different subtypes of psoriasis patients, with the highest in scalp psoriasis, followed by palmoplantar psoriasis, and a less significant increase in patients with psoriatic arthritis.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

Article Oncology

Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker

Riaz Abdulla, Jofy Devasia Puthenpurackal, Sneha M. Pinto, Punchappady Devasya Rekha, Yashwanth Subbannayya

Summary: In this study, we identified and evaluated the diagnostic value of autoantibodies in serum samples of OSCC patients using immunome protein array profiling. We found a number of differential autoantibodies associated with OSCC, including NUBP2. Immunohistochemical validation showed positive staining of NUBP2 in the majority of OSCC cases. Overall, the serum autoantibodies identified in this study, including NUBP2, have the potential to serve as biomarkers for early diagnosis or screening of OSCC.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Psychiatry

A pilot-study to examine motor cortical plasticity as a neuro-marker of antipsychotic treatment response in schizophrenia

Aishwarya Sachdeva, Urvakhsh Meherwan Mehta, Jagadisha Thirthalli

Summary: In a pilot study of 15 untreated first-episode schizophrenia participants, the impact of pre-treatment motor cortical plasticity on the response to antipsychotic medications was investigated. It was found that participants with cortical plasticity in the opposite direction showed greater improvements in positive symptoms. This association remained significant even after accounting for multiple comparisons and potential confounders through linear regression. Inter-individual variability in cortical plasticity may serve as a potential predictive biomarker in schizophrenia, but more research is needed for replication.

ASIAN JOURNAL OF PSYCHIATRY (2023)

Add to Collection

Article Dermatology

Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Rosa Giuseppa Angileri, Federico Bardazzi, Nicoletta Bernardini, Martina Burlando, Carlo G. Carrera, Andrea Chiricozzi, Paolo Dapavo, Valentina Dini, Gabriella Fabbrocini, Francesca Maria Gaiani, Marco Galluzzo, Claudia Giofre, Claudio Guarneri, Francesco Loconsole, Giovanna Malara, Lorenzo Marcelli, Matteo Megna, Stefano Piaserico, Marina Talamonti, Antonio Costanzo, Alessandra Narcisi

Summary: This retrospective study on 233 patients with moderate-to-severe plaque psoriasis who had an inadequate response to ustekinumab showed that guselkumab was more effective in achieving PASI 75/90/100 compared to ustekinumab.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Interleukin-6 Could Be a Potential Prognostic Factor in Ambulatory Elderly Patients with Stable Heart Failure: Results from a Pilot Study

Marina Povar-Echeverria, Pablo Esteban Auquilla-Clavijo, Emmanuel Andres, Francisco Javier Martin-Sanchez, Maria Victoria Laguna-Calle, Alberto Elpidio Calvo-Elias, Noel Lorenzo-Villalba, Manuel Mendez-Bailon

Summary: This study analyzed the clinical characteristics of heart failure patients with elevated IL-6 levels, revealing that these patients are more likely to have atrial fibrillation, diabetes mellitus, dyslipidemia, anemia, and renal failure, with a higher mortality rate.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Role of Polyamines as Biomarkers in Lymphoma Patients: A Pilot Study

Donatella Coradduzza, Adriana Ghironi, Emanuela Azara, Nicola Culeddu, Sara Cruciani, Angelo Zinellu, Margherita Maioli, Maria Rosaria De Miglio, Serenella Medici, Claudio Fozza, Ciriaco Carru

Summary: Lymphomas are a heterogeneous group of neoplastic diseases with complex clinicopathological characteristics. Inflammation plays a significant role in their development, and measuring specific substances in serum may enhance diagnosis and comparison of patient groups.

DIAGNOSTICS (2022)

Add to Collection

Letter Dermatology

Lesional Inflammatory Profile in Hidradenitis Is Not Driven IL-1

Allard R. J. V. Vossen, Kelsey R. van Straalen, Edwin F. Florencia, Errol P. Prens

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)

Add to Collection

Article Pharmacology & Pharmacy

Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers

Thomas P. Buters, Pieter W. Hameeteman, Iris M. E. Jansen, Floris C. van Hindevoort, Wouter Ten Voorde, Edwin Florencia, Michelle Osse, Marieke L. de Kam, Hendrika W. Grievink, Mascha Schoonakker, Amit A. Patel, Simon Yona, Derek W. Gilroy, Erik Lubberts, Jeffrey Damman, Gary Feiss, Robert Rissmann, Manon A. A. Jansen, Jacobus Burggraaf, Matthijs Moerland

Summary: This study aimed to characterize the intradermal LPS response in healthy volunteers as a local inflammation model for clinical pharmacology studies. Results showed that intradermal LPS administration induced a visible response, with acute interleukin and tumor necrosis factor protein response followed by different cellular responses. The study suggests that intradermal LPS administration may be a valuable inflammation model for evaluating the pharmacological activity of anti-inflammatory compounds.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Add to Collection

Editorial Material Dermatology

Clinical translation of hidradenitis suppurativa genetic studies requires global collaboration

A. J. Jabbour, K. R. van Straalen, A. Colvin, E. P. Prens, L. Petukhova

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection

Review Pharmacology & Pharmacy

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa

Pim Aarts, Koen Dudink, Allard R. J. V. Vossen, Kelsey R. van Straalen, Christine B. Ardon, Errol P. Prens, Hessel H. van der Zee

Summary: Hidradenitis suppurativa is a chronic autoimmune skin disease characterized by inflammatory nodules and abscesses due to the upregulation of various immune cells and pro-inflammatory cytokines. While adalimumab is currently the only approved drug for HS, other biologics and small molecules targeting different inflammatory pathways are being researched and utilized.

DRUGS (2021)

Add to Collection

Letter Dermatology

No Evident Systemic Terminal Complement Pathway Activation in Hidradenitis Suppurativa

Lisette M. Prens, Christine B. Ardon, Kelsey R. van Straalen, Hessel H. van der Zee, A. J. Seelen, Jon D. Laman, Errol P. Prens, Barbara Horvath, Jeffrey Damman

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Add to Collection

Article Immunology

Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation

Xiaofei Xu, Errol Prens, Edwin Florencia, Pieter Leenen, Luis Boon, Patrick Asmawidjaja, Anne-Marie Mus, Erik Lubberts

Summary: The up-regulation of IL-19 and IL-24 induced by IL-17A in skin stromal cells contributes to keratinocyte proliferation. Depletion of IL-10 leads to increased expression of IL-23/IL-17 pathway related cytokines followed by significant up-regulation of IL-19 and IL-24.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Letter Dermatology

Prevalence and Clinical Characteristics of Hidradenitis Suppurativa Phenotypes in a Large Dutch Cohort

Koen Dudink, Pim Aarts, Christine B. Ardon, Allard R. J. V. Vossen, Sterre B. L. Koster, Jonathan F. van den Bosch, Errol P. Prens, Hessel H. van der Zee

DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Needle-free jet injection-induced small-droplet aerosol formation during intralesional bleomycin therapy

Liora Bik, Albert Wolkerstorfer, Vazula Bekkers, Errol P. Prens, Merete Haedersdal, Daniel Bonn, Martijn B. A. van Doorn

Summary: Needle-free jet injectors can generate small-droplet aerosols of chemotherapeutics, potentially posing risks to patients and healthcare personnel. Adequate room ventilation and smoke evacuation are effective safety measures to reduce aerosol exposure during clinical practice.

LASERS IN SURGERY AND MEDICINE (2022)

Add to Collection

Article Dermatology

Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial

Gayle van der Kraaij, Celine Busard, Juul van den Reek, Stef Menting, Annelie Musters, Barbara Hutten, Menno de Rie, Wouter Ouwerkerk, Sun-Jine Van Bezooijen, Errol Prens, Theo Rispens, Annick de Vries, Elke de Jong, Wim de Kort, Jo Lambert, Martijn van Doorn, Phyllis Spuls

Summary: This study evaluated the efficacy, safety, and pharmacokinetic profile of adalimumab combined with methotrexate in the treatment of chronic plaque psoriasis. The results showed that combination therapy resulted in fewer patients showing antidrug antibodies and a trend towards improved treatment response.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa

Pim Aarts, Johanna C. van Huijstee, Aviel Ragamin, Joanne L. Reeves, Catherine van Montfrans, Hessel H. van der Zee, Errol P. Prens

Summary: This study validated two digital wound measurement tools for measuring the surface area of larger and concave wounds in patients with HS, demonstrating excellent concurrent validity and reliability. This enables the tools to be used reliably in clinical research and daily practice, and opens the possibility for broader applications such as telemonitoring of wound care at home.

DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Clindamycin-benzoyl peroxide gel compared with clindamycin lotion for hidradenitis suppurativa; a randomized controlled assessor blinded intra-patient pilot study.

Pim Aarts, Joanne L. Reeves, Christine B. Ardon, Hessel H. van der Zee, Errol P. Prens

Summary: This study compared the clinical efficacy of two treatments for mild to moderate HS and found that both treatments were effective, suggesting that they can be used interchangeably to prevent antibiotic resistance.

DERMATOLOGY (2023)

Add to Collection

Article Dermatology

A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteers

Wouter ten Voorde, Mahdi Saghari, Jiry Boltjes, Marieke. L. L. de Kam, Ahnjili Zhuparris, Gary Feiss, Thomas. P. P. Buters, Errol. P. P. Prens, Jeffrey Damman, Tessa Niemeyer-van der Kolk, Matthijs Moerland, Jacobus Burggraaf, Martijn B. A. van Doorn, Robert Rissmann

Summary: This study comprehensively characterized skin punch biopsy-induced wounds in healthy volunteers using a battery of multimodal tests, and developed a valuable wound healing model for standardized testing of novel treatments.

EXPERIMENTAL DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial

Astrid M. van Huizen, Gayle E. van der Kraaij, Celine I. Busard, Wouter Ouwerkerk, Juul M. P. A. van den Reek, Stef P. Menting, Errol P. Prens, Theo Rispens, Annick de Vries, Elke M. G. J. de Jong, Jo Lambert, Martijn B. A. van Doorn, Phyllis I. Spuls

Summary: This study compared the long-term effectiveness and safety of the combination of methotrexate and adalimumab with adalimumab monotherapy in patients with moderate to severe plaque type psoriasis. The results showed a trend towards longer drug survival in the combination therapy group, but no significant difference was found compared to the monotherapy group. Similar conclusions were drawn regarding the efficacy, safety, pharmacokinetics, and immunogenicity of the drugs. Overall, combination therapy may have a better effect in individual patients.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Article Engineering, Biomedical

Needle-free electronically controlled jet injection with corticosteroids in recalcitrant keloid scars: a retrospective study and patient survey

Liora Bik, Ixora Elmzoon, Albert Wolkerstorfer, Errol P. Prens, Martijn B. A. van Doorn

Summary: This study found that intralesional triamcinolone acetonide treatment using an electronically controlled pneumatic injector (EPI) is an effective, well-tolerated, and highly satisfactory treatment for patients with recalcitrant keloids.

LASERS IN MEDICAL SCIENCE (2023)

Add to Collection

Meeting Abstract Dermatology

Disease association of anti-CEL autoantibodies in hidradenitis suppurativa

Giulio Macchiarella, Vanessa Cornacchione, Lukas Roth, Christian Loesche, Elisabetta Traggiai, Alexandre Avrameas, Errol P. Prens, Till A. Rohn, Ben Roediger

EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.